CompletedNot Applicable

Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema

Egypt68 participantsStarted 2022-06-29

Plain-language summary

Statement of the problem: The problem will be stated in a questionary form: "Which will be more effective endermologie or negative pressure therapy in reducing limb circumference and volume in postmastectomy lymphedema?". Hypothesis: It will be hypothesized that: There is no significant difference between endermologie and negative pressure therapy in reducing circumference and limb volume in post mastectomy lymphedema.

Who can participate

Age range40 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Only females will participate in the study. * Patients' age was ranged between 40-60 years. * All patients will suffer from post mastectomy lymphedema. * All patients have a modified radical mastectomy. * All patients suffer from grade II lymphedema without skin changes one year post mastectomy(as defined by the International Society of Lymphology). * All patients are right-dominant hand. * All patients enrolled to the study will have their informed consent. Exclusion Criteria: * The potential participants will be excluded if they meet one of the following criteria: * primary lymphedema. * Diabetes mellitus. * Pregnancy. * Recurrent cancer. * Current or recent cellulitis. * Current metastases. * Venous thrombosis. * Photosensitivity. * Phlebitis in development stage. * Infection. * Receiving anti-coagulant treatment.

What they're measuring

Measuring Disability of the arm, shoulder and hand

Timeframe: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb function before and after treatment

Limb volume measurement

Timeframe: Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb volume and decrease of lymph-edema

Trial details

NCT IDNCT05761353

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More Mastectomy; Lymphedema trials